Cargando…
IL-1R2 expression in human gastric cancer and its clinical significance
Background: Interleukin-1 receptor type II (IL-1R2), also known as CD121b, is a member of the IL-1 receptor family. IL-1R2 acts as negative regulator of the IL-1 system, modulating IL-1 availability for the signaling receptor. IL-1R2 is abnormally expressed in many human inflammatory diseases and ca...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011276/ https://www.ncbi.nlm.nih.gov/pubmed/33704402 http://dx.doi.org/10.1042/BSR20204425 |
_version_ | 1783673208915886080 |
---|---|
author | Yuan, Maoling Wang, Lei Huang, Hao Li, Yuan Zheng, Xiao Shao, Qi Jiang, Jingting |
author_facet | Yuan, Maoling Wang, Lei Huang, Hao Li, Yuan Zheng, Xiao Shao, Qi Jiang, Jingting |
author_sort | Yuan, Maoling |
collection | PubMed |
description | Background: Interleukin-1 receptor type II (IL-1R2), also known as CD121b, is a member of the IL-1 receptor family. IL-1R2 acts as negative regulator of the IL-1 system, modulating IL-1 availability for the signaling receptor. IL-1R2 is abnormally expressed in many human inflammatory diseases and cancers, and has important clinical significance. The present study was designed to investigate IL-1R2 expression in human gastric cancer (GC) tissues and the associated clinical implications. Methods: Immunohistochemistry was used to identify the clinical significance and prognostic value of IL-1R2 expression in GC tissues. We investigated IL-1R2 expression in GC tissues, cells, and serum using real-time PCR (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) assays. Results: IL-1R2 was highly expressed in GC tissues, and the overall survival in patients with advanced GC and high IL-1R2 expression was significantly poorer than that in patients with advanced GC and low IL-1R2 expression. Moreover, IL-1R2 mRNA levels in GC tissues and most GC cells were higher than those in para-cancer tissues and GES1 human gastric mucosal epithelial cells. The level of plasma-soluble IL-1R2 in GC patients was higher than that of the healthy control group. Conclusion: Increased IL-1R2 levels are involved in the initiation and progression of human GC, and IL-1R2 might be employed to develop immunotherapeutic approaches targeting GC. |
format | Online Article Text |
id | pubmed-8011276 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Portland Press Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80112762021-04-08 IL-1R2 expression in human gastric cancer and its clinical significance Yuan, Maoling Wang, Lei Huang, Hao Li, Yuan Zheng, Xiao Shao, Qi Jiang, Jingting Biosci Rep Cancer Background: Interleukin-1 receptor type II (IL-1R2), also known as CD121b, is a member of the IL-1 receptor family. IL-1R2 acts as negative regulator of the IL-1 system, modulating IL-1 availability for the signaling receptor. IL-1R2 is abnormally expressed in many human inflammatory diseases and cancers, and has important clinical significance. The present study was designed to investigate IL-1R2 expression in human gastric cancer (GC) tissues and the associated clinical implications. Methods: Immunohistochemistry was used to identify the clinical significance and prognostic value of IL-1R2 expression in GC tissues. We investigated IL-1R2 expression in GC tissues, cells, and serum using real-time PCR (RT-PCR) and enzyme-linked immunosorbent assay (ELISA) assays. Results: IL-1R2 was highly expressed in GC tissues, and the overall survival in patients with advanced GC and high IL-1R2 expression was significantly poorer than that in patients with advanced GC and low IL-1R2 expression. Moreover, IL-1R2 mRNA levels in GC tissues and most GC cells were higher than those in para-cancer tissues and GES1 human gastric mucosal epithelial cells. The level of plasma-soluble IL-1R2 in GC patients was higher than that of the healthy control group. Conclusion: Increased IL-1R2 levels are involved in the initiation and progression of human GC, and IL-1R2 might be employed to develop immunotherapeutic approaches targeting GC. Portland Press Ltd. 2021-03-26 /pmc/articles/PMC8011276/ /pubmed/33704402 http://dx.doi.org/10.1042/BSR20204425 Text en © 2021 The Author(s). http://creativecommons.org/licenses/by/4.0/ This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (http://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Cancer Yuan, Maoling Wang, Lei Huang, Hao Li, Yuan Zheng, Xiao Shao, Qi Jiang, Jingting IL-1R2 expression in human gastric cancer and its clinical significance |
title | IL-1R2 expression in human gastric cancer and its clinical
significance |
title_full | IL-1R2 expression in human gastric cancer and its clinical
significance |
title_fullStr | IL-1R2 expression in human gastric cancer and its clinical
significance |
title_full_unstemmed | IL-1R2 expression in human gastric cancer and its clinical
significance |
title_short | IL-1R2 expression in human gastric cancer and its clinical
significance |
title_sort | il-1r2 expression in human gastric cancer and its clinical
significance |
topic | Cancer |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011276/ https://www.ncbi.nlm.nih.gov/pubmed/33704402 http://dx.doi.org/10.1042/BSR20204425 |
work_keys_str_mv | AT yuanmaoling il1r2expressioninhumangastriccanceranditsclinicalsignificance AT wanglei il1r2expressioninhumangastriccanceranditsclinicalsignificance AT huanghao il1r2expressioninhumangastriccanceranditsclinicalsignificance AT liyuan il1r2expressioninhumangastriccanceranditsclinicalsignificance AT zhengxiao il1r2expressioninhumangastriccanceranditsclinicalsignificance AT shaoqi il1r2expressioninhumangastriccanceranditsclinicalsignificance AT jiangjingting il1r2expressioninhumangastriccanceranditsclinicalsignificance |